微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.84% | 0.52% | 7.56% | 34/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 3.57% | 76.73% | -51.16% | 10/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 7.31% | 42.77% | 18.48% | 39/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 6.17% | 28.54% | 61.52% | 44/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 3.82% | 45.25% | 89.11% | 42/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 2.02% | 51.88% | -60.55% | 45/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 5.12% | -33.59% | 6.67% | 61/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 4.8% | -26.27% | 82.51% | 59/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 2.63% | -37.23% | 97.74% | 67/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.33% | -31.79% | -82.75% | 65/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 7.71% | 53.89% | 18.43% | 52/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 6.51% | 60.74% | 55.37% | 50/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 4.19% | 140.8% | 114.87% | 57/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.95% | 77.27% | -61.08% | 58/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 5.01% | -51.17% | 23.7% | 93/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 4.05% | -45.93% | 132.76% | 90/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 1.74% | -56.72% | 58.18% | 100/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 1.1% | -50% | -89.28% | 84/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 10.26% | -41.57% | 36.98% | 80/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 7.49% | -56.2% | 86.32% | 78/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 4.02% | -78.7% | 82.73% | 89/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2.2% | -62.26% | -87.47% | 71/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 17.56% | -60.6% | 2.69% | 57/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 17.1% | 2% | -9.38% | 32/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 18.87% | -9.45% | 223.67% | 21/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 5.83% | 2% | -86.92% | 15/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 44.57% | 27.6% | 113.87% | 2/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-06-30 | 20.84% | 82.01% | -40.34% | 3/141 | 6.76% | 祥生医疗 | 28.56% | 行业排名> |
| 2018-12-31 | 34.93% | 14.37% | 14.37% | 8/141 | 14.23% | 心脉医疗 | 31.04% | 行业排名> |
| 2017-12-31 | 30.54% | 46.47% | 46.47% | 14/141 | 14.51% | 新华医疗 | 13.55% | 行业排名> |
| 2016-12-31 | 20.85% | -34.21% | 82.1% | 21/141 | 16.44% | 安旭生物 | 48.71% | 行业排名> |
| 2016-06-30 | 11.45% | 2% | -63.87% | 10/141 | 6.35% | 迈瑞医疗 | 38.33% | 行业排名> |